These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 9652880
1. Safety, tolerability, and neurohormonal changes of the combination captopril plus losartan in the early postinfarction period: a pilot study. Di Pasquale P, Bucca V, Scalzo S, Paterna S. Cardiovasc Drugs Ther; 1998 May; 12(2):211-6. PubMed ID: 9652880 [Abstract] [Full Text] [Related]
3. Does the addition of losartan improve the beneficial effects of ACE inhibitors in patients with anterior myocardial infarction? A pilot study. Di Pasquale P, Bucca V, Scalzo S, Cannizzaro S, Giubilato A, Paterna S. Heart; 1999 Jun; 81(6):606-11. PubMed ID: 10336919 [Abstract] [Full Text] [Related]
4. Additional beneficial effects of canrenoate in patients with anterior myocardial infarction on ACE-inhibitor treatment. A pilot study. Di Pasquale P, Cannizzaro S, Giubilato A, Vitrano MG, Scandurra A, Giambanco F, Saccone G, Sarullo FM, Paterna S. Ital Heart J; 2001 Feb; 2(2):121-9. PubMed ID: 11256540 [Abstract] [Full Text] [Related]
5. [Is the reduction of the plasma levels of endothelin in the acute and sub-acute stage of myocardial infarct one of the beneficial effects of early treatment with ace inhibitors?]. Di Pasquale P, Bucca V, Scalzo S, Cannizzaro S, Longo AM, Alessi V, D'Amato M, Manusia F, Magatti MF. G Ital Cardiol; 1996 Jun; 26(6):673-80. PubMed ID: 8803588 [Abstract] [Full Text] [Related]
8. The combination ace-inhibitors plus canreonate in patients with anterior myocardial infarction: safety and tolerability study. Di Pasquale P, Alessi V, Barberi O, Scandurra A, Bucca V, Maringhini G, Scalzo S, Paterna S. Int J Cardiol; 2001 Feb; 77(2-3):119-27; discussion 128-9. PubMed ID: 11182173 [Abstract] [Full Text] [Related]
16. ACE-inhibition plus mineralocorticoid antagonism versus ACE-inhibition alone in patients with anterior myocardial infarction. Di Pasquale P, Cannizzaro S, Scandurra A, Giubilato A, Scalzo S, Paterna S. Cardiovasc Drugs Ther; 2001 Jul 15; 15(4):309-14. PubMed ID: 11800414 [Abstract] [Full Text] [Related]
17. Antihypertensive efficacy and tolerability of once daily losartan potassium compared with captopril in patients with mild to moderate essential hypertension. Mallion JM, Bradstreet DC, Makris L, Goldberg AI, Halasz S, Sweet CS, Lim NY, Madonna O. J Hypertens Suppl; 1995 Jul 15; 13(1):S35-41. PubMed ID: 18800454 [Abstract] [Full Text] [Related]
18. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Pitt B, Segal R, Martinez FA, Meurers G, Cowley AJ, Thomas I, Deedwania PC, Ney DE, Snavely DB, Chang PI. Lancet; 1997 Mar 15; 349(9054):747-52. PubMed ID: 9074572 [Abstract] [Full Text] [Related]
19. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives. Azizi M, Chatellier G, Guyene TT, Murieta-Geoffroy D, Ménard J. Circulation; 1995 Aug 15; 92(4):825-34. PubMed ID: 7641363 [Abstract] [Full Text] [Related]
20. [Effects of the long-term treatment with losartan and captopril and of the abrupt cessation on circadian blood pressure profile]. Gorbunov VM, Savina LV, Metelitsa VI, Deev AD. Eksp Klin Farmakol; 2001 Aug 15; 64(2):45-50. PubMed ID: 11548448 [Abstract] [Full Text] [Related] Page: [Next] [New Search]